Molecular strategies in genetic diagnosis of transthyretin‐related hereditary amyloidosis

Abstract

Transthyretin-related hereditary (TTR) amyloidoses represent a clinically heterogeneous group of diseases associated with various point mutations of the TTR gene. We propose a molecular strategy for the diagnosis of this group of disorders.